Literature DB >> 21982886

Retinoblastoma in Jordan: an epidemiological study (2006-2010).

Imad Jaradat1, Yacoub A Yousef, Mustafa Mehyar, Iyad Sultan, Samer Khurma, Khalil Al-Rawashded, Matt Wilson, Ibrahim Qaddoumi, Ahmed Salem, Ibrahim Alnawaiseh.   

Abstract

BACKGROUND AND
OBJECTIVE: The epidemiological characteristics of retinoblastoma have been extensively studied in developed countries, however epidemiological data is scarce in the Middle East. We present a de- tailed epidemiological analysis of retinoblastoma in Jordan in an attempt to aid national and regional strategies for improved cancer surveillance and control. DESIGN AND
SETTING: Retrospective review of retinoblastoma cases presenting to the sole and exclusive ocular oncology referral center in Jordan. PATIENTS AND METHODS: Forty children (59 eyes) presenting with clinically and/or histologically confirmed retinoblastomas were treated at King Hussein Cancer Center (Amman, Jordan) between January 2006 and December 2010. This case series included 28 boys and 12 girls. Data relating to age at diagnosis, laterality, gender, treatment modality and survival were recorded.
RESULTS: The mean age-adjusted incidence of retinoblastoma in Jordan was 9.32 cases per million children per year for children aged 0-5 years. The male: female ratio was 2.3:1. Bilateral cases were encountered in 19 pa- tients (47.5%) while 21 patients (52.5%) harbored unilateral retinoblastoma. At the time of follow-up, 38 patients (95%) were alive. Overall, 40 eyes (67.8%) were successfully preserved without the need for enucleation.
CONCLUSIONS: The national epidemiological data gathered in this study indicates that the incidence of retinoblastoma in Jordan is similar to that reported in various countries of the world. Jordanian boys, however, are at significantly higher risk for developing retinoblastoma than age-matched girls. Furthermore, Jordanian patients are more likely to harbor bilateral retinoblastoma.

Entities:  

Mesh:

Year:  2011        PMID: 21982886     DOI: 10.5144/1658-3876.2011.126

Source DB:  PubMed          Journal:  Hematol Oncol Stem Cell Ther


  9 in total

1.  Mutational analysis of the RB1 gene and the inheritance patterns of retinoblastoma in Jordan.

Authors:  Yacoub A Yousef; Abdelghani Tbakhi; Maysa Al-Hussaini; Ibrahim AlNawaiseh; Ala Saab; Amal Afifi; Maysa Naji; Mona Mohammad; Rasha Deebajah; Imad Jaradat; Iyad Sultan; Mustafa Mehyar
Journal:  Fam Cancer       Date:  2018-04       Impact factor: 2.375

2.  Improving Medical Students' Awareness About Retinoblastoma: A Practical Strategy.

Authors:  Mutasem Elfalah; Tamara AlNawaiseh; Dima Atoum; Ahmad AlKhassawneh; Mona Mohammad; Ibrahim AlNawaiseh; Yacoub A Yousef
Journal:  Clin Ophthalmol       Date:  2022-06-07

3.  Retinoblastoma major review with updates on Middle East management protocols.

Authors:  Ihab Saad Othman
Journal:  Saudi J Ophthalmol       Date:  2012-04

4.  Retinoblastoma in the democratic republic of congo: 20-year review from a tertiary hospital in kinshasa.

Authors:  Aimé Kazadi Lukusa; Michel Ntetani Aloni; Bertin Kadima-Tshimanga; Moïse Mvitu-Muaka; Jean Lambert Gini Ehungu; René Ngiyulu; Pépé Ekulu Mfutu; Aléine Budiongo Nzazi
Journal:  J Cancer Epidemiol       Date:  2012-04-26

5.  The Predictive Value of the Eighth Edition of the Clinical TNM Staging System for the Likelihood of Eye Salvage for Intraocular Retinoblastoma by Systemic Chemotherapy and Focal Therapy.

Authors:  Yacoub A Yousef; Mona Mohammad; Mustafa Mehyar; Iyad Sultan; Maysa Al-Hussaini; Joud Alhourani; Hadeel Halalsheh; Jakub Khzouz; Imad Jaradat; Ibrahim Qaddoumi; Ibrahim Al-Nawaiseh
Journal:  J Pediatr Hematol Oncol       Date:  2021-08-01       Impact factor: 1.170

6.  Management outcome(s) in eyes with retinoblastoma previously inadequately treated with systemic chemotherapy alone without focal therapy.

Authors:  Yacoub A Yousef; Rashed M Nazzal; Mohammed B Khalil; Rasha Deebajah; Mustafa Mehyar; Shatha Hajja; Mona Mohammad; Reem Al Jabary; Imad Jaradat; Iyad Sultan; Ibrahim Al Nawaiseh
Journal:  Oman J Ophthalmol       Date:  2017 May-Aug

7.  Familial Retinoblastoma: Raised Awareness Improves Early Diagnosis and Outcome.

Authors:  Ibrahim Al-Nawaiseh; Aseel Q Ghanem; Yacoub A Yousef
Journal:  J Ophthalmol       Date:  2017-03-02       Impact factor: 1.909

8.  Retinoblastoma: A Sixteen-Year Review of the Presentation, Treatment, and Outcome from a Tertiary Care Institute in Northern India.

Authors:  Usha Singh; Deeksha Katoch; Savleen Kaur; Mangat Ram Dogra; Deepak Bansal; Rakesh Kapoor
Journal:  Ocul Oncol Pathol       Date:  2017-07-05

9.  Enucleation and evisceration at a tertiary care hospital in a developing country.

Authors:  Osama H Ababneh; Eman A AboTaleb; Mohammad A Abu Ameerh; Yacoub A Yousef
Journal:  BMC Ophthalmol       Date:  2015-09-11       Impact factor: 2.209

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.